Ambroxol Hydrochloride: A Pharmaceutical Intermediate with Potential Parkinson's Benefits
Discover the dual potential of Ambroxol Hydrochloride in respiratory care and neurodegenerative disease research.
Get a Quote & SampleProduct Core Value
Ambroxol Hydrochloride
Ambroxol Hydrochloride is a critical pharmaceutical intermediate with established efficacy as a mucolytic agent, commonly used in cough and respiratory medications. Beyond its traditional applications, emerging research highlights its potential as a novel therapeutic agent for Parkinson's disease, showing promise in slowing disease progression by enhancing GCase enzyme activity.
- Explore the Ambroxol Hydrochloride CAS 23828-92-4 as a key component in pharmaceutical formulations for respiratory relief.
- Investigate the groundbreaking research connecting Ambroxol Hydrochloride Parkinson's disease treatment and its impact on GCase levels.
- Learn about the development journey of this essential pharmaceutical intermediate Ambroxol Hydrochloride, from respiratory care to neuroprotection.
- Understand the clinical implications and ongoing Ambroxol Hydrochloride clinical trials aiming to validate its Parkinson's therapeutic benefits.
Key Advantages
Dual Therapeutic Potential
Ambroxol Hydrochloride offers a unique dual application, serving effectively as a mucolytic agent for respiratory conditions while showing significant promise in the experimental treatment of Parkinson's disease.
Established Safety Profile
With a long history of use in Europe as an over-the-counter cough medicine, Ambroxol Hydrochloride possesses a well-established safety and tolerability profile, making it a reliable choice for pharmaceutical development.
Potential for Disease Modification
The ability of Ambroxol Hydrochloride to potentially slow the progression of Parkinson's disease by increasing GCase activity represents a significant advancement in neurodegenerative treatment research, offering hope for a disease-modifying therapy.
Key Applications
Respiratory Health
Utilized as a potent mucolytic agent, Ambroxol Hydrochloride effectively thins and loosens mucus in the respiratory tract, easing coughs and facilitating expectoration in patients with bronchitis and other respiratory ailments.
Neuroscience Research
Emerging research indicates Ambroxol Hydrochloride's capacity to increase GCase enzyme levels, suggesting a potential role in treating lysosomal storage disorders and Parkinson's disease by enhancing cellular waste removal.
Pharmaceutical Intermediate
As a high-quality pharmaceutical intermediate, it is crucial for the synthesis of various drug formulations, ensuring consistent quality and efficacy for end-user medications.
Drug Repurposing
The repurposing of Ambroxol Hydrochloride for Parkinson's disease exemplifies how existing, safe drugs can offer new therapeutic solutions, potentially accelerating treatment availability and reducing development costs.